Conducting pediatric trials in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Optimizing clinical trials for pediatric obesity treatment

Incorporating the voice of patient in pediatric assent forms

SGLT2-Inhibitoren als nierenschützende Agenten für pädiatrische Patienten mit chronischen Nierenerkrankungen

Explore the benefits of SGLT2 inhibitors as renoprotective agents for pediatric patients. Fortrea's blog provides insights into diabetes medication and renal protection.

Implementing a novel approach for recruiting a seasonal pediatric vaccine mega-trial

This case study demonstrates how Fortrea developed a novel approach to successfully delivery a large, industry-sponsored Phase III clinical trial to prevent hospitalization of infants due to a seasonal and dangerous illness.

MASH trial design

Development pathways and trial design for liver cirrhosis secondary to MASH

MASH clinical trials

Read our lessons learned from 14 MASH trials over the last four years.

Understanding alcohol-associated liver disease: a focus on alcohol-associated hepatitis

Learn about the challenges of advancing clinical studies in Alcohol Associated Liver Disease

Enrolling adolescents into adult clinical trials

Get insights on bringing safe and effective treatments to children and adolescents sooner.

Empowering young voices in pediatric clinical trials: Fortrea’s commitment to child rights and participation

Learn about the experiences of the young participants involved in the clinical trials.

Tag der seltenen Krankheiten: Feier des Fortschritts und Hoffnung für die Zukunft

Join Fortrea in celebrating Rare Disease Day, highlighting progress in medical research and hope for the future.